There is often more than one cause of the child's sleep disturbances. Without taking a careful history to identify them, finding a solution to the child's sleep disturbances can be elusive. Although children with cerebral palsy and developmental delay may have sleep disorders, management is complex and requires specialist input. Management of these patients will not be covered in this topic.
Obstructive sleep apnoea (OSA)
Adenotonsillectomy is considered first-line treatment in children with OSA and adenotonsillar hypertrophy.[30]Marcus CL, Brooks LJ, Draper KA, et al; American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012 Sep;130(3):576-84.
http://pediatrics.aappublications.org/content/130/3/576.long
http://www.ncbi.nlm.nih.gov/pubmed/22926173?tool=bestpractice.com
[34]Ishman SL, Maturo S, Schwartz S, et al. Expert consensus statement: management of pediatric persistent obstructive sleep apnea after adenotonsillectomy. Otolaryngol Head Neck Surg. 2023 Feb;168(2):115-30.
https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.159
http://www.ncbi.nlm.nih.gov/pubmed/36757810?tool=bestpractice.com
[60]Mitchell RB. Adenotonsillectomy for obstructive sleep apnea in children: outcome evaluated by pre- and postoperative polysomnography. Laryngoscope. 2007 Oct;117(10):1844-54.
http://www.ncbi.nlm.nih.gov/pubmed/17721406?tool=bestpractice.com
[88]Bitners AC, Arens R. Evaluation and management of children with obstructive sleep apnea syndrome. Lung. 2020 Apr;198(2):257-70.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171982
http://www.ncbi.nlm.nih.gov/pubmed/32166426?tool=bestpractice.com
[89]Goldbart AD, Goldman JL, Veling MC, et al. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005 Aug 1;172(3):364-70.
http://www.atsjournals.org/doi/full/10.1164/rccm.200408-1064OC
http://www.ncbi.nlm.nih.gov/pubmed/15879419?tool=bestpractice.com
[90]Alkhalil M, Lockey R. Pediatric obstructive sleep apnea syndrome (OSAS) for the allergist: update on the assessment and management. Ann Allergy Asthma Immunol. 2011 Aug;107(2):104-9.
http://www.ncbi.nlm.nih.gov/pubmed/21802017?tool=bestpractice.com
This is generally curative in 79% to 92% of children, although some studies have demonstrated complete resolution of obstruction in smaller numbers, especially in obese children.[91]Mitchell RB, Kelly J. Outcomes and quality of life following adenotonsillectomy for sleep-disordered breathing in children. ORL J Otorhinolaryngol Relat Spec. 2007;69(6):345-8.
http://www.ncbi.nlm.nih.gov/pubmed/18033971?tool=bestpractice.com
[92]Mitchell RB, Kelly J. Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg. 2007 Jul;137(1):43-8.
http://www.ncbi.nlm.nih.gov/pubmed/17599563?tool=bestpractice.com
[93]Tauman R, Gulliver TE, Krishna J, et al. Persistence of obstructive sleep apnea syndrome in children after adenotonsillectomy. J Pediatr. 2006 Dec;149(6):803-8.
http://www.ncbi.nlm.nih.gov/pubmed/17137896?tool=bestpractice.com
One large multicentred trial has demonstrated improvement in behaviour and quality of life in children with OSA undergoing adenotonsillectomy relative to controls.[94]Marcus CL, Moore RH, Rosen CL, et al; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013 Jun 20;368(25):2366-76.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756808
http://www.ncbi.nlm.nih.gov/pubmed/23692173?tool=bestpractice.com
One small randomised controlled trial in otherwise healthy children, between 2 and 4 years of age, with mild to moderate OSA showed significant improvement in quality of life following adenotonsillectomy for those with moderate disease, but no major difference between those treated and those not treated with mild disease. This suggests watchful waiting is a recommended strategy in children with mild disease, but further studies are needed.[95]Fehrm J, Nerfeldt P, Browaldh N, et al. Effectiveness of adenotonsillectomy vs watchful waiting in young children with mild to moderate obstructive sleep apnea: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2020;146(7):647–654.
http://www.ncbi.nlm.nih.gov/pubmed/32463430?tool=bestpractice.com
Adenotonsillectomy for OSA improved most quality-of-life and symptom severity measurements in children aged approximately 5 to 10 years, but resulted in clinically significant weight gain even in children overweight at baseline.[94]Marcus CL, Moore RH, Rosen CL, et al; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013 Jun 20;368(25):2366-76.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3756808
http://www.ncbi.nlm.nih.gov/pubmed/23692173?tool=bestpractice.com
[96]Venekamp RP, Hearne BJ, Chandrasekharan D, et al. Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children. Cochrane Database Syst Rev. 2015;(10):CD011165.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011165.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/26465274?tool=bestpractice.com
[97]Garetz SL, Mitchell RB, Parker PD, et al. Quality of life and obstructive sleep apnea symptoms after pediatric
adenotonsillectomy. Pediatrics. 2015 Feb;135(2):e477-86.
http://www.ncbi.nlm.nih.gov/pubmed/25601979?tool=bestpractice.com
[98]Katz ES, Moore RH, Rosen CL, et al. Growth after adenotonsillectomy for obstructive sleep apnea: an RCT. Pediatrics. 2014 Aug;134(2):282-9.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187239
http://www.ncbi.nlm.nih.gov/pubmed/25070302?tool=bestpractice.com
When mild residual disease persists after adenotonsillectomy, the use of montelukast and/or intranasal budesonide has been demonstrated to improve or resolve the obstruction.[34]Ishman SL, Maturo S, Schwartz S, et al. Expert consensus statement: management of pediatric persistent obstructive sleep apnea after adenotonsillectomy. Otolaryngol Head Neck Surg. 2023 Feb;168(2):115-30.
https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.159
http://www.ncbi.nlm.nih.gov/pubmed/36757810?tool=bestpractice.com
[99]Kheirandish L, Goldbart AD, Gozal D. Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics. 2006 Jan;117(1):e61-6.
http://www.ncbi.nlm.nih.gov/pubmed/16396849?tool=bestpractice.com
The US Food and Drug Administration has strengthened its warnings for montelukast about the risk of serious behaviour and mood-related changes.[100]US Food & Drug Administration. FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. March 2020 [internet publication].
https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug
In children younger than 24 months, there is sometimes reluctance to proceed with adenotonsillectomy because of concern about bleeding and other postoperative complications.[101]Brigance JS, Miyamoto RC, Schilt P, et al. Surgical management of obstructive sleep apnea in infants and young toddlers. Otolaryngol Head Neck Surg. 2009 Jun;140(6):912-6.
http://www.ncbi.nlm.nih.gov/pubmed/19467414?tool=bestpractice.com
In these patients continuous positive airway pressure (CPAP) is initiated, as for those with persistent OSA after adenotonsillectomy, or in instances when surgery is not feasible.[34]Ishman SL, Maturo S, Schwartz S, et al. Expert consensus statement: management of pediatric persistent obstructive sleep apnea after adenotonsillectomy. Otolaryngol Head Neck Surg. 2023 Feb;168(2):115-30.
https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.159
http://www.ncbi.nlm.nih.gov/pubmed/36757810?tool=bestpractice.com
[102]Marcus CL, Ward SL, Mallory GB, et al. Use of nasal continuous positive airway pressure as treatment of childhood obstructive sleep apnea. J Pediatr. 1995 Jul;127(1):88-94.
http://www.ncbi.nlm.nih.gov/pubmed/7608817?tool=bestpractice.com
[103]Amos L, Afolabi-Brown O, Gault D, et al. Age and weight considerations for the use of continuous positive airway pressure therapy in pediatric populations: an American Academy of Sleep Medicine position statement. J Clin Sleep Med. 2022 Aug 1;18(8):2041-3.
https://jcsm.aasm.org/doi/10.5664/jcsm.10098
http://www.ncbi.nlm.nih.gov/pubmed/35638127?tool=bestpractice.com
Successfully using CPAP requires patience, a multidisciplinary approach, and close follow-up to achieve good compliance and adherence. Behavioural interventions to improve adherence with CPAP, long a mainstay of paediatric sleep medicine, are increasingly being recognised as useful in adult sleep medicine.[104]Askland K, Wright L, Wozniak DR, et al. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea. Cochrane Database Syst Rev. 2020 Apr 7;(4):CD007736.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007736.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/32255210?tool=bestpractice.com
[
]
How do mixed interventions (educational, supportive, behavioral) compare with usual care for promoting continuous positive airway pressure (CPAP) device usage in adults with obstructive sleep apnea?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.3210/fullShow me the answer
[
]
How do educational interventions compare with usual care for promoting continuous positive airway pressure (CPAP) device usage in adults with obstructive sleep apnea?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.3208/fullShow me the answer
In children who are not treated with surgery, intranasal budesonide and montelukast may be used as additional treatments for mild OSA, and OSA worsened by allergy. However, a 2020 systematic review of anti-inflammatory medications for OSA in non-surgically treated children found insufficient evidence in support of intranasal corticosteroids, and only short-term beneficial effects of treatment with montelukast.[105]Kuhle S, Hoffmann DU, Mitra S, et al. Anti-inflammatory medications for obstructive sleep apnoea in children. Cochrane Database Syst Rev. 2020 Jan 17;(1):CD007074.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007074.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/31978261?tool=bestpractice.com
If underlying craniofacial structural abnormalities are present, craniofacial, maxillary, and/or mandibular surgeries are sometimes indicated.[34]Ishman SL, Maturo S, Schwartz S, et al. Expert consensus statement: management of pediatric persistent obstructive sleep apnea after adenotonsillectomy. Otolaryngol Head Neck Surg. 2023 Feb;168(2):115-30.
https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1002/ohn.159
http://www.ncbi.nlm.nih.gov/pubmed/36757810?tool=bestpractice.com
Surgery may also be indicated if a patient cannot tolerate CPAP.[106]Mitchell RB, Call E, Kelly J. Diagnosis and therapy for airway obstruction in children with Down syndrome. Arch Otolaryngol Head Neck Surg. 2003 Jun;129(6):642-5.
http://www.ncbi.nlm.nih.gov/pubmed/12810469?tool=bestpractice.com
[107]Lye KW, Waite PD, Meara D, et al. Quality of life evaluation of maxillomandibular advancement surgery for treatment of obstructive sleep apnea. J Oral Maxillofac Surg. 2008 May;66(5):968-72.
http://www.ncbi.nlm.nih.gov/pubmed/18423288?tool=bestpractice.com
Orthodontic interventions such as maxillary expansion have been demonstrated to treat OSA effectively.[108]Villa MP, Malagola C, Pagani J. Rapid maxillary expansion in children with obstructive sleep apnea syndrome: 12-month follow-up. Sleep Med. 2007 Mar;8(2):128-34.
http://www.ncbi.nlm.nih.gov/pubmed/17239661?tool=bestpractice.com
Addressing and treating other underlying issues that may be contributing to the OSA is important as well. This includes treating chronic allergic rhinitis, gastro-oesophageal reflux, or obesity; avoiding environmental tobacco smoke or exacerbating medications; and avoiding certain sleep positions if the OSA is only present while maintaining them.
Chronic insomnia disorder
Behavioural interventions should be the mainstay of treatment for chronic insomnia disorder in children.[9]Macias MI, Malhotra S. Behavioral insomnia of childhood. Am J Respir Crit Care Med. 2021 Apr 15;203(8):P20-P21.
https://www.atsjournals.org/doi/epdf/10.1164/rccm.2038P20?role=tab
http://www.ncbi.nlm.nih.gov/pubmed/33856280?tool=bestpractice.com
[109]Moturi S, Avis K. Assessment and treatment of common pediatric sleep disorders. Psychiatry (Edgmont). 2010 Jun;7(6):24-37.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898839
http://www.ncbi.nlm.nih.gov/pubmed/20622943?tool=bestpractice.com
[110]Mindell JA, Kuhn BR, Lewin DS, et al. Behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006;29:1263-1276. [Erratum in: Sleep. 2006;29:1380.]
http://www.aasmnet.org/Resources/PracticeParameters/Review_NightWakingsChildren.pdf
http://www.ncbi.nlm.nih.gov/pubmed/17068979?tool=bestpractice.com
[111]Price AM, Wake M, Ukoumunne OC, et al. Five-year follow-up of harms and benefits of behavioral infant sleep intervention: randomized trial. Pediatrics. 2012 Oct;130(4):643-51.
http://www.ncbi.nlm.nih.gov/pubmed/22966034?tool=bestpractice.com
To facilitate the success of these behavioural interventions, parents should be educated on general positive sleep habits. These include implementing a consistent bedtime routine, ensuring a regular sleep schedule for both night-time sleep and daytime naps, and making sure that the child is in bed for an age-appropriate amount of time. All of these methods have been shown to be effective.[63]Morgenthaler TI, Owens J, Alessi C, et al. Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006 Oct;29(10):1277-81.
http://www.aasmnet.org/Resources/PracticeParameters/PP_NightWakingsChildren.pdf
http://www.ncbi.nlm.nih.gov/pubmed/17068980?tool=bestpractice.com
If the child has multiple carers, it is also extremely important that they agree upon the approach to be taken; conflicting messages often result in the child not understanding what is expected of them, which leads to unsuccessful behavioural modification.[5]American Academy of Sleep Medicine. International Classification of Sleep Disorders – third edition, text revision (ICSD-3-TR). Westchester, IL: American Academy of Sleep Medicine; 2023.[9]Macias MI, Malhotra S. Behavioral insomnia of childhood. Am J Respir Crit Care Med. 2021 Apr 15;203(8):P20-P21.
https://www.atsjournals.org/doi/epdf/10.1164/rccm.2038P20?role=tab
http://www.ncbi.nlm.nih.gov/pubmed/33856280?tool=bestpractice.com
The American Thoracic Society outlines a number of treatments that can be used for sleep-onset difficulties: extinction (e.g., putting the child to bed awake, closing the door, and leaving him/her to cry him/herself to sleep); modified extinction (e.g., putting the child to bed awake, leaving the room, and returning to check in on him/her at set intervals, giving the child the message that he/she needs to go to sleep while reassuring the child that he/she has not been abandoned); extinction with parental presence (e.g., where the child is put to bed awake and the parent sits in a chair in the bedroom with his/her back to the child without actually going over to the child to soothe him/her to sleep); faded bedtime with positive bedtime routines (e.g., in which the child is put to bed later than usual while being given positive bedtime routines); scheduled awakenings (e.g., in which the child is awakened at fixed intervals to pre-empt his/her own patterns of awakening).[9]Macias MI, Malhotra S. Behavioral insomnia of childhood. Am J Respir Crit Care Med. 2021 Apr 15;203(8):P20-P21.
https://www.atsjournals.org/doi/epdf/10.1164/rccm.2038P20?role=tab
http://www.ncbi.nlm.nih.gov/pubmed/33856280?tool=bestpractice.com
Though all are generally found to be effective, there is insufficient evidence to recommend one intervention over another. Parental acceptance of the modified extinction or extinction with parental presence method tends to be higher than the unmodified extinction method.[63]Morgenthaler TI, Owens J, Alessi C, et al. Practice parameters for behavioral treatment of bedtime problems and night wakings in infants and young children. Sleep. 2006 Oct;29(10):1277-81.
http://www.aasmnet.org/Resources/PracticeParameters/PP_NightWakingsChildren.pdf
http://www.ncbi.nlm.nih.gov/pubmed/17068980?tool=bestpractice.com
All interventions are associated with a reduction in tantrums.[112]Bruni O, Novelli L. Sleep disorders in children. BMJ Clin Evid. 2010 Sep 27;2010. pii: 2304.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217667
http://www.ncbi.nlm.nih.gov/pubmed/21418676?tool=bestpractice.com
The treatment of limit-setting behaviours also requires education as to the nature of the problem, and, depending upon the age of the child, active involvement of the child in modifying the sleep-related behaviour. With younger children who refuse to stay in bed, the use of a gate at either the child’s or parent’s bedroom door can be highly effective in establishing boundaries without causing additional distress (e.g., anxiety caused by closing the bedroom door).[113]Owens JA, Moore M. Insomnia in infants and young children. Pediatr Ann. 2017 Sep 1;46(9):e321-26.
http://www.ncbi.nlm.nih.gov/pubmed/28892546?tool=bestpractice.com
With older children, delineating the desired outcome and devising a graded reward system to give positive reinforcement for following through works well.[65]Meltzer LJ. Clinical management of behavioral insomnia of childhood: treatment of bedtime problems and night wakings in young children. Behav Sleep Med. 2010;8(3):172-89.
https://www.tandfonline.com/doi/full/10.1080/15402002.2010.487464
http://www.ncbi.nlm.nih.gov/pubmed/20582760?tool=bestpractice.com
If there is a significant component of separation anxiety that has resulted in the parent having to sleep in the same bedroom as the child (or the child in the parent's bed or bedroom), implementing a modified extinction protocol for this, similar to what might be applied for sleep-onset difficulties, can be effective. For example, the parent might initially sleep on a mattress on the floor of the child's bedroom for the entire night, followed by the parent leaving the bedroom once the child has fallen asleep, followed by the parent beginning to leave the bedroom for short intervals as the child is falling asleep that gradually lengthen until the child no longer requires the parent's presence.
Melatonin is not a treatment for chronic insomnia disorder, except in very specific circumstances. Although it is available in many countries without prescription, the effectiveness and long-term effects of its use in children are largely unknown.[114]Koopman-Verhoeff ME, van den Dries MA, van Seters JJ, et al. Association of sleep problems and melatonin use in school-aged dhildren. JAMA Pediatr. 2019 Sep 1;173(9):883-85.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646973
http://www.ncbi.nlm.nih.gov/pubmed/31329217?tool=bestpractice.com
Melatonin has been used to induce sleep in children with ADHD and autistic spectrum disorder with good results, although the optimal dosage is still unclear, and determining it is made difficult by the fact that it is not a regulated substance and can vary widely between manufacturers.[112]Bruni O, Novelli L. Sleep disorders in children. BMJ Clin Evid. 2010 Sep 27;2010. pii: 2304.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217667
http://www.ncbi.nlm.nih.gov/pubmed/21418676?tool=bestpractice.com
[115]McDonagh MS, Holmes R, Hsu F. Pharmacologic treatments for sleep disorders in children: a systematic review. J Child Neurol. 2019 Apr;34(5):237-47.
http://www.ncbi.nlm.nih.gov/pubmed/30674203?tool=bestpractice.com
[116]Hoebert M, van der Heijden KB, van Geijlswijk IM, et al. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009 Aug;47(1):1-7.
http://www.ncbi.nlm.nih.gov/pubmed/19486273?tool=bestpractice.com
[117]Andersen IM, Kaczmarska J, McGrew SG, et al. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008 May;23(5):482-5.
http://www.ncbi.nlm.nih.gov/pubmed/18182647?tool=bestpractice.com
[118]Guénolé F, Godbout R, Nicolas A, et al. Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. Sleep Med Rev. 2011 Dec;15(6):379-87.
http://www.ncbi.nlm.nih.gov/pubmed/21393033?tool=bestpractice.com
[119]Williams Buckley A, Hirtz D, Oskoui M, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020 Mar 3;94(9):392-404.
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32051244
http://www.ncbi.nlm.nih.gov/pubmed/32051244?tool=bestpractice.com
Initiation and dosing should be done in consultation with a specialist.[120]American Academy of Sleep Medicine. Health advisory: melatonin use in children and adolescents. Sept 2022 [internet publication].
https://aasm.org/advocacy/position-statements/melatonin-use-in-children-and-adolescents-health-advisory
Behavioural interventions should be used first in otherwise healthy children.[111]Price AM, Wake M, Ukoumunne OC, et al. Five-year follow-up of harms and benefits of behavioral infant sleep intervention: randomized trial. Pediatrics. 2012 Oct;130(4):643-51.
http://www.ncbi.nlm.nih.gov/pubmed/22966034?tool=bestpractice.com
Melatonin may give a small added benefit.[112]Bruni O, Novelli L. Sleep disorders in children. BMJ Clin Evid. 2010 Sep 27;2010. pii: 2304.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217667
http://www.ncbi.nlm.nih.gov/pubmed/21418676?tool=bestpractice.com
Delayed sleep-wake phase disorder (DSWPD)
Treating DSWPD involves keeping to a regular schedule, both weekdays and weekends, during the school year and while on holidays, with special emphasis on the wake-up time. Exposure to bright light in the mornings needs to be encouraged, as well as reinforcement of the notion that the wake-up time denotes the hour at which the patient gets out of bed, not at which he/she enters into 2 hours of drifting in and out of sleep while continuing to lie in bed. Education about proper sleep hygiene, sleep drives, and the effects of caffeine and certain medications is important. Reduction of exposure to bright light at least 2 hours prior to bedtime is important.
Sleep hygiene involves elimination of caffeine consumption in the 8 hours prior to sleep; minimising bright light exposure in the 2 hours prior to bedtime; removal of electronic media from the bedroom, including televisions, video games, computers, and mobile phones, and avoidance of falling asleep wearing headphones; removal of pets from the bedroom; keeping the bedroom dark, quiet, and at an ambient temperature.
In instances where the circadian phase shift is extreme, using chronotherapy to further delay the bedtime by 3-hour increments around the clock until it is brought back to the desired hour can be very effective. Chronotherapy entails postponing bedtime by 3-hour increments, in order to bring the circadian clock back in synch with the external clock. It is often used with people with significant DSWPD, in whom it is easier to resynchronise by staying up later and later rather than trying to go to sleep earlier and earlier. It is also important to keep in mind that if there is a large circadian phase shift, exposure to bright light in the morning may in fact only serve to further delay the circadian sleep-onset time.
Using melatonin adjunctively has been shown effective to advance circadian phase.[121]Szeinberg A, Borodkin K, Dagan Y. Melatonin treatment in adolescents with delayed sleep phase syndrome. Clin Pediatr (Phila). 2006 Nov;45(9):809-18.
http://www.ncbi.nlm.nih.gov/pubmed/17041168?tool=bestpractice.com
[122]Van Geijlswijk IM, Korzilius HP, Smits MG, et al. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep. 2010 Dec;33(12):1605-14.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982730/?tool=pubmed
http://www.ncbi.nlm.nih.gov/pubmed/21120122?tool=bestpractice.com
Melatonin has been used to induce sleep in children with ADHD and autistic spectrum disorder with good results.[112]Bruni O, Novelli L. Sleep disorders in children. BMJ Clin Evid. 2010 Sep 27;2010. pii: 2304.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217667
http://www.ncbi.nlm.nih.gov/pubmed/21418676?tool=bestpractice.com
[118]Guénolé F, Godbout R, Nicolas A, et al. Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. Sleep Med Rev. 2011 Dec;15(6):379-87.
http://www.ncbi.nlm.nih.gov/pubmed/21393033?tool=bestpractice.com
[119]Williams Buckley A, Hirtz D, Oskoui M, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020 Mar 3;94(9):392-404.
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32051244
http://www.ncbi.nlm.nih.gov/pubmed/32051244?tool=bestpractice.com
[123]Bendz LM, Scates AC. Melatonin treatment for insomnia in pediatric patients with attention-deficit/hyperactivity disorder. Ann Pharmacother. 2010 Jan;44(1):185-91.
http://www.ncbi.nlm.nih.gov/pubmed/20028959?tool=bestpractice.com
The optimal dosage is still unclear, and determination is made difficult by the fact that it is not a regulated substance and can vary widely between manufacturers.[116]Hoebert M, van der Heijden KB, van Geijlswijk IM, et al. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009 Aug;47(1):1-7.
http://www.ncbi.nlm.nih.gov/pubmed/19486273?tool=bestpractice.com
[117]Andersen IM, Kaczmarska J, McGrew SG, et al. Melatonin for insomnia in children with autism spectrum disorders. J Child Neurol. 2008 May;23(5):482-5.
http://www.ncbi.nlm.nih.gov/pubmed/18182647?tool=bestpractice.com
The behavioural, schedule, and sleep hygiene issues should be addressed first. It should be made clear that these are really what will make a difference, and that the problem will not be solved just by taking a pill. There are no formal criteria for starting melatonin. Initiation and dosing should be supervised by a specialist.[120]American Academy of Sleep Medicine. Health advisory: melatonin use in children and adolescents. Sept 2022 [internet publication].
https://aasm.org/advocacy/position-statements/melatonin-use-in-children-and-adolescents-health-advisory
Narcolepsy
The child should take frequent scheduled naps. Various drugs are approved to treat narcolepsy in children, including stimulants (e.g., methylphenidate, dexamfetamine, modafinil, armodafinil), as well as other drugs, including sodium oxybate (and other oxybate salts), pitolisant, and solriamfetol.[124]Golicki D, Bala MM, Niewada M, et al. Modafinil for narcolepsy: systematic review and meta-analysis. Med Science Moni. 2010 Aug;16(8):RA177-86.
http://www.ncbi.nlm.nih.gov/pubmed/20671626?tool=bestpractice.com
[125]Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021 Sep 1;17(9):1881-93.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636351
http://www.ncbi.nlm.nih.gov/pubmed/34743789?tool=bestpractice.com
[126]Bassetti CLA, Kallweit U, Vignatelli L, et al. European guideline and expert statements on the management of narcolepsy in adults and children. Eur J Neurol. 2021 Sep;28(9):2815-30.
https://onlinelibrary.wiley.com/doi/10.1111/ene.14888
http://www.ncbi.nlm.nih.gov/pubmed/34173695?tool=bestpractice.com
[127]Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med. 2021 Sep 1;17(9):1895-1945.
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/34743790
http://www.ncbi.nlm.nih.gov/pubmed/34743790?tool=bestpractice.com
Fluoxetine, venlafaxine, and clomipramine have been used with some success.[128]Mignot E, Nishino S. Emerging therapies in narcolepsy-cataplexy. Sleep. 2005 Jun;28(6):754-63.
http://www.ncbi.nlm.nih.gov/pubmed/16477963?tool=bestpractice.com
These agents should be prescribed under specialist use only. See Narcolepsy.